Michael Andrew Holloway insider trades

Open-market stock purchases and sales by Michael Andrew Holloway, Director at Lixte Biotechnology Holdings, Inc, from SEC Form 4 filings since Aug 15, 2025.

Recent trades

DateStockTradeValue
Apr 15, 2026LIXT Lixte Biotechnology Holdings, IncBought (not open market)—
Apr 15, 2026LIXT Lixte Biotechnology Holdings, IncSold (not open market)$89.8K

Companies traded

  • LIXT Lixte Biotechnology Holdings, Inc: other filings, last Apr 15, 2026

Get free alerts when Michael Andrew Holloway files a new trade →